Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

RFLP analysis of the MHC class III region defines unique haplotypes for the non-obese diabetic, cataract Shionogi and the non-obese non-diabetic mouse strains


The non-obese diabetic (NOD) mouse strain which spontaneously develops diabetes is a model for human Type 1 (insulin-dependent) diabetes mellitus. At least one of several genes controlling diabetes in the NOD mouse has been mapped to the MHC. Although previous experiments have implicated the MHC class II genes in the development of the disease, the existence of other MHC linked susceptibility genes has not been ruled out. In order to identify these susceptibility genes we have further characterized the MHC haplotype of the NOD mouse and two non-diabetic sister strains, the non-obese non-diabetic (NON) and cataract Shionogi (CTS). We have examined the mouse MHC class III region for the presence of homologous genes to 17 newly isolated human MHC class III region genes (G1, G2, G4, G6, G7a/valyl-tRNA synthetase, HSP70, G8, G9, G10, G12, G13, G14, G15, G16, G17 and G18). We detect unique hybridizing DNA fragments for 16 of the 17 genes in six inbred mouse strains (NOD, NON, CTS, B10, BALB/c and CBA/J) indicating that this part of the H-2 region is similar to the human MHC class III region. Using a panel of restriction enzymes we have defined RFLPs for 6 (G2, G6, HSP70, G12, G16, G18) of the 16 cross-hybridizing probes. The RFLPs demonstrate that NOD, NON and CTS mouse strains each have a distinct MHC haplotype in the MHC class III region.


  1. 1.

    Hattori M, Buse JB, Jackson RA et al. (1986) The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. Science 231: 733–735

  2. 2.

    Prochazka M, Leiter EH, Serreze DV, Coleman DL (1987) Three recessive loci required for insulin-dependent diabetes in non-obese diabetic mice. Science 237: 286–289

  3. 3.

    Acha-Orbea H, McDevitt HO (1987) The first external domain of the non-obese diabetic mouse class II I-A beta chain is unique. Proc Natl Acad Sci USA 84: 2435–2439

  4. 4.

    Uehira M, Uno M, Kurner T et al. (1989) Development of autoimmune insulitis is prevented in E alpha d but not in A beta k NOD transgenic mice. Int Immunol 1: 209–213

  5. 5.

    Lund T, O'Reilly L, Hutchings P et al. (1990) Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain. Nature 345: 727–729

  6. 6.

    Miyazaki T, Uno M, Uehira M et al. (1990) Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in non-obese diabetic mice. Nature 345: 722–724

  7. 7.

    Slattery RM, Kjer NL, Allison J, Charlton B, Mandel TE, Miller JF (1990) Prevention of diabetes in non-obese diabetic I-Ak transgenic mice. Nature 345: 724–726

  8. 8.

    Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y (1980) Breeding of a non-obese, diabetic strain of mice. Exp Anim 29: 1–13

  9. 9.

    Ikegami H, Makino S, Harada M, Eisenbarth GS, Hattori M (1988) The cataract Shionogi mouse, a sister strain of the non-obese diabetic mouse: similar class II but different class I gene products. Diabetologia 31: 254–258

  10. 10.

    Koide Y, Yoshida TO (1990) The unique nucleotide sequence of the A beta gene in the NOD mouse is shared with its nondiabetic sister strains, the ILI and the CTS mouse. Int Immunol 2: 189–192

  11. 11.

    Fujishima Y, Koide Y, Kaidoh T, Nishimura M, Yoshida TO (1989) Restriction fragment length polymorphism analysis of major histocompatibility complex genes in the non-obese diabetic mouse strain and its non-diabetic sister strains. Diabetologia 32: 118–125

  12. 12.

    Lund T, Simpson E, Cooke A (1990) Restriction fragment length polymorphisms in the major histocompatibility complex of the non-obese diabetic mouse. J Autoimmun 3: 289–298

  13. 13.

    Makino S, Kishimoto Y, Kunimoto K, Kawaguchi J, Uchida K (1991) Localization of the MHC-linked diabetogenic genes of the NOD mouse by using congenic strains. Diabetes Res Clin Pract 14 [Suppl 1]: S40

  14. 14.

    Trowsdale J, Hanson I, Mockridge I, Beck S, Townsend A, Kelly A (1990) Sequences encoded in the class II region of the MHC related to the ‘ABC’ superfamily of transporters. Nature 348: 741–744

  15. 15.

    Deverson EV, Gow IR, Coadwell WJ, Monaco JJ, Butcher GW, Howard JC (1990) MHC class II region encoding proteins related to the multidrug resistance family of transmembrane transporters. Nature 348: 738–741

  16. 16.

    Spies T, Bresnahan M, Bahram S et al. (1990) A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature 348: 744–747

  17. 17.

    Cho SG, Attaya M, Monaco JJ (1991) New class II-like genes in the murine MHC. Nature 353: 573–576

  18. 18.

    Sargent CA, Dunham I, Campbell RD (1989) Identification of multiple HTF-island associated genes in the human major histocompatibility complex class III region. Embo J 8: 2305–2312

  19. 19.

    Spies T, Bresnahan M, Strominger JL (1989) Human major histocompatibility complex contains a minimum of 19 genes between the complement cluster and HLA-B. Proc Natl Acad Sci USA 86: 8955–8958

  20. 20.

    Kendall E, Sargent CA, Campbell RD (1990) Human major histocompatibility complex contains a new cluster of genes between the HLA-D and complement C4 loci. Nucleic Acids Res 18: 7251–7257

  21. 21.

    Milner CM, Campbell RD (1990) Structure and expression of the three MHC-linked HSP70 genes. Immunogenetics 32: 242–251

  22. 22.

    Hsieh SL, Campbell RD (1991) Evidence that gene G7a in the human major histocompatibility complex encodes valyl-tRNA synthetase. Biochem J 278: 807–816

  23. 23.

    Feinberg AP, Vogelstein B (1983) A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132: 6–13

  24. 24.

    Gaskin HR, Prochazka M, Nadeau JH, Henson VW, Leiter EH (1990) Localization of a mouse heat shock Hsp70 gene within the H-2 complex. Immunogenetics 32: 286–289

  25. 25.

    Snoek M, Jansen M, Olavesen MG, Campbell RD, Teuscher C, van Vugt H (1993) Three Hsp70 genes are located in the C4-H-2D region, possible candidates for the Orch-1 locus. Genomics 15: 350–356

  26. 26.

    Snoek M, Groot PC, Spies T, Campbell RD, Demant P (1991) Fine mapping of the crossover-sites in the C4-H-2D region of H-2 recombinant mouse strains. Immunogenetics 34: 409–412

  27. 27.

    Lafuse WP, Lanning D, Spies T, David CS (1992) PFGE mapping and RFLP analysis of the S/D region of the mouse H-2 complex. Immunogenetics 36: 110–116

  28. 28.

    Satoh J, Seino H, Abo T et al. (1989) Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in non-obese diabetic mice. J Clin Invest 84: 1345–1348

  29. 29.

    Jacob CO, Aiso S, Michie SA, McDevitt HO, Acha OH (1990) Prevention of diabetes in non-obese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and inter leukin 1. Proc Natl Acad Sci USA 87: 968–972

  30. 30.

    Rembecki RM, Kumar V, David CS, Bennett M (1988) Polymorphism of Hh-1, the mouse hemopoietic histocompatibility locus. Immunogenetics 28: 158–170

  31. 31.

    Demant P (1985) Corticosteroid-induced cleft palate: cis interaction of MHC genes and hybrid resistance. Immunogenetics 22: 183–188

  32. 32.

    Teuscher C, Gasser DL, Woodward SR, Hickey WF (1990) Experimental allergic orchitis in mice. VI. Recombinations within the H-2S/H-2D interval define the map position of the H-2-associated locus controlling disease susceptibility. Immunogenetics 32: 337–344

  33. 33.

    Figueroa F, Klein D, Tewarson S, Klein J (1982) Evidence for placing the Neu-1 locus within the mouse H-2 complex. J Immunol 129: 2089–2093

  34. 34.

    Müller U, Stephan D, Philippsen P, Steinmetz M (1987) Orientation and molecular map position of the complement genes in the mouse MHC. Embo J 6: 369–373

  35. 35.

    Trowsdale J, Ragoussis J, Campbell RD (1991) Map of the human MHC. Immunol Today 12: 443–446

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Lund, T., Shaikh, S., Kendall, E. et al. RFLP analysis of the MHC class III region defines unique haplotypes for the non-obese diabetic, cataract Shionogi and the non-obese non-diabetic mouse strains. Diabetologia 36, 727–733 (1993).

Download citation

Key words

  • MHC class III region
  • non-obese diabetic mouse
  • non-obese non-diabetic mouse
  • cataract Shionogi mouse
  • Type 1 (insulin-dependent) diabetes mellitus
  • restriction fragment length polymorphisms